Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy
about
Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused reviewGenetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathyHypertrophic cardiomyopathy in childhoodA novel custom resequencing array for dilated cardiomyopathyResearch priorities in sarcomeric cardiomyopathiesFunctional Analysis of Two Novel Mutations in TWIST1 Protein Motifs Found in Ventricular Septal Defect PatientsRare variant mutations identified in pediatric patients with dilated cardiomyopathyCoding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathyA novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractilityClinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathyCoding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathyFamilial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivityThin filament mutations: developing an integrative approach to a complex disorderA novel arginine to tryptophan (R144W) mutation in troponin T (cTnT) gene in an indian multigenerational family with dilated cardiomyopathy (FDCM)Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugsGenotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals.Imaging phenotype vs genotype in nonhypertrophic heritable cardiomyopathies: dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathyDistinct troponin C isoform requirements in cardiac and skeletal muscleA Drosophila melanogaster model of diastolic dysfunction and cardiomyopathy based on impaired troponin-T function.A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin bindingGenotype-specific pathogenic effects in human dilated cardiomyopathy.Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy.Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.Molecular etiology of idiopathic cardiomyopathy.Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy.Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation.The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy.Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.Troponin T is essential for sarcomere assembly in zebrafish skeletal muscle.Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativityClinical and genetic issues in dilated cardiomyopathy: a review for genetics professionalsFunctional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.Genetics of inherited cardiomyopathy.Trbp regulates heart function through microRNA-mediated Sox6 repression.Establishing disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human cardiac myosin.The miscommunicative cardiac cell: when good proteins go bad.Cardiomyopathy-Related Mutations in Cardiac Troponin C, L29Q and G159D, Have Divergent Effects on Rat Cardiac Myofiber Contractile Dynamics.Myocardial regulatory proteins and heart failure.A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress
P2860
Q21129229-BC513033-AB2B-4D93-B009-AC5F6E318058Q24288778-13D2DBFA-1065-4E47-AB5C-701BAD8E9A8AQ24599577-DD252505-316B-42BB-9463-7D7F7E683D00Q24602132-8B3C4D7C-F52D-46C8-BBDC-AC35F0C9044AQ27694507-B3C04736-1CA0-4754-8119-6A81730B9AAAQ28115006-579E89AD-11FF-44D5-8E18-9EE47DB117BBQ28235313-94454057-B809-4E2C-BD8A-849F7FBB644AQ28243560-44FE0DA8-42E5-4210-932D-AEAFF7DC1539Q28265634-880C9EFE-8517-463C-8610-830D8414CE42Q28268628-0F193D26-2460-4986-A9D6-7F391FA74CECQ28275501-F1037E9C-10B3-424B-8D61-DA3876D3F831Q28287994-0E7846F1-7DBA-4E88-AEAD-8EF72674F1C9Q28307606-4E492765-EFD3-4FF4-A470-725EF870C7E7Q28540344-C39718AE-70AA-4B39-8C55-763CCCF53618Q28607749-CD4391BA-8979-4326-9A41-563B287CB135Q30248233-07BB418B-8F37-4F18-957F-94CF290DA23BQ30473247-FF944A34-230D-41B4-8FC6-835F0C5AE1F7Q30497167-1726C416-FECF-4C3E-80BF-FEA670FC7CDEQ30660058-7AB47287-AE73-4A22-A3DB-96379EA5EC93Q33885078-3C151B36-C428-450B-A6E0-FE4301763EF4Q33903336-44E33D11-8334-4C7E-B9BB-4606F748D68FQ34080849-88096B37-DC05-4B6D-A45D-33A59477B4C3Q34160551-4BEE42BD-EFD7-461D-A369-DD449F50EDD8Q34171604-2A4761E7-DEC4-487D-96FD-8FF1A40A8ED8Q34195576-DE9A20AD-1A00-4363-A7A3-2D75B6DFE725Q34248530-646818E1-8A99-417E-8C85-91B44F16351EQ34327150-2D7B28BF-EA25-421B-9ECD-F80C537B8F35Q34399188-51D3AE12-7E09-47FC-885E-B87777EA411FQ34541495-0FA3ED47-3BA1-4977-97BD-AB00263C9D21Q34930971-A1C39F0F-D7F5-4CEC-A1F2-1366A03352BDQ34980505-7B0EB0F0-0C27-454E-B414-01D0E17BF77DQ35054950-47F2DE80-1953-461E-A9D8-3C90BF793859Q35311290-1BB8711B-B243-4519-AE18-47E281F9CD76Q35721684-CDEE3624-875B-49B2-8930-257A5BB6248CQ35798130-063B7E17-6161-4EA5-B265-1E974A53925BQ35820287-007D2354-C928-47B7-AE1E-0478B4DF26F0Q36225108-CF96AD64-B4B1-4F92-A50E-9899F5B1840FQ36248424-DC27B079-D7B2-4DA2-B737-64EF3A81F66CQ36323149-351C78DE-CE0A-4753-9A8A-4EF665026E06Q36422401-81EEAC01-E5C3-4166-B490-9E2EF614EC14
P2860
Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Severe disease expression of c ...... opathic dilated cardiomyopathy
@ast
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en-gb
Severe disease expression of c ...... opathic dilated cardiomyopathy
@nl
type
label
Severe disease expression of c ...... opathic dilated cardiomyopathy
@ast
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en-gb
Severe disease expression of c ...... opathic dilated cardiomyopathy
@nl
prefLabel
Severe disease expression of c ...... opathic dilated cardiomyopathy
@ast
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en-gb
Severe disease expression of c ...... opathic dilated cardiomyopathy
@nl
P2093
P921
P3181
P1476
Severe disease expression of c ...... opathic dilated cardiomyopathy
@en
P2093
Charles Redwood
Margaret Burke
Perry M Elliott
Ross T Murphy
William J McKenna
P304
P3181
P356
10.1016/J.JACC.2004.08.027
P407
P577
2004-11-16T00:00:00Z